For larger genes such as ABCA4 (Stargardt disease) and USH2A (Usher syndrome type 2A), dual-AAV systems have been developed to overcome size limitations, while CRISPR/Cas9-based genome editing has been explored for precise mutation correction. This evidence concerns the gene ABCA4 and Usher syndrome type 2.